US Patent 11932882 Reverse transcriptase variants
Patent 11932882 was granted and assigned to 10X Genomics on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+423 characters)
US Patent 11932882 Reverse transcriptase variants
Article
Patent abstract
The application provides compositions including engineered reverse transcriptases with at least one altered reverse-transcriptase related activity. The engineered reverse transcriptases or reverse transcription enzymes unexpectedly exhibit one or more altered reverse transcriptase related activities such as but not limited to altered template switching efficiency, altered transcription efficiency or both.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Carolina Cuellar0
Derek Hunter Vallejo0
Katherine Pfeiffer0
Sonya A. Clark0
Date of Patent
March 19, 2024
0Patent Application Number
178374970
Date Filed
June 10, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11932882 Reverse transcriptase variants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.